Boult Wade Tennant
Bulletins » AI inventorship in the UK – Consultation says “no”.

Just as the days (in the UK at least) start getting shorter the UK government has published its response following the consultation on changes to UK patent law to recognise Artificial Intelligence (AI) inventors.

As readers of our previous bulletin may remember, shortly after the UK Court of Appeal decided that in the UK an “inventor” had to be a human, the UK Government launched a consultation asking for comments on possible changes to the law to account for AI inventors in relation to UK patents and patent applications. The changes proposed ranged from simply defining the inventor as the human responsible for the AI system, through formally recognising named “AI inventors”, all the way to the creating of an entirely new intellectual property right to protect AI generated inventions.

Option 0 
In true computer scientist fashion, the UK Government in their response have have gone for “Option 0”. In this case option 0 was to simply maintain the law as it is – which in the view of the Court of Appeal above is a no to AI inventors. This follows the majority of the respondents to the consultation, who also argued for no change.

It seems that there were concerns that a unilateral change to the definition of the inventor under UK law could disadvantage applicants – for example, what would an AI named as inventor on a UK patent mean for the corresponding US or EPO applications if those jurisdictions did not themselves allow or recognise AI inventors? What would be the ownership rules around the resulting inventions?

Anyone hoping that this consultation would provide a quick solution to the AI inventor question is likely to be disappointed.

“Crisis? What Crisis?”
Interestingly, there was a degree of scepticism amongst respondents in the consultation as to whether AI systems are at a level where they are truly devising inventions – rather than just acting as an assistive tool.

As mentioned previously, the recent litigation around the naming of AIs as inventors has all proceeded on the assumptions that in the relevant patent applications (a) there is an invention and (b) the AI did indeed “devise” it. This has allowed the legal point – whether an AI can be named as inventor under the current law – to be explored.

The responses to this consultation do question, indirectly, whether these assumptions reflect present reality, and if a real problem even exists yet. Some suggested that the status quo is good enough to allow protection of the current level of “AI-assisted” inventions. This is a difficult contention to test of course, as missed opportunities are always hard to pin down. With the pace of technological change in the AI space theoretical problems can soon enough become real problems and this is not likely to be the last word on the notion of AI inventors in UK law.

It’s (often) later than you think.

Relevant sectors
Aerospace
  • Commercial aviation
  • Defence and security
  • Space and satellites
  • Unmanned aerial vehicles
Artificial Intelligence and Machine Learning
Automotive
  • Autonomous vehicles
  • Electric vehicles
  • Engines
Biotechnology
  • Antibody engineering
  • Antibody manufacture and formulation
  • Bioinformatics
  • Biosimilars
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • GM crops
  • Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
  • Next generation sequencing
  • Nucleic acid synthesis
  • Personalised medicine/disease biomarkers
  • Recombinant protein production and purification
  • Stem cell therapies
  • Supplementary protection certificates (SPCs)
  • Synthetic biology
  • Therapeutic antibodies
  • Vaccinology (e.g. viral vectors; mRNA vaccines)
  • Women’s health products
Chemicals
  • Agrochemicals
  • Catalysts
  • Dispersions and colloids
  • Lubricants
  • Polymers and plastics
Communications and Networks
  • Cloud computing
  • Internet of things (IOT)
  • Oceanography, marine
  • Wired and wireless networks
Computing and Software
  • Artificial intelligence and machine learning
  • Bioinformatics
  • Blockchain and distributed ledgers
  • Communications and networks
  • Computer games
  • Data and software security, cryptography and digital rights management (DRM)
  • Data management and storage, databases and data compression
  • Digital assistants, virtual assistants and software agents
  • Fintech and adtech
  • Machine vision
  • Metaverse, virtual reality (VR) and augmented reality (AR)
  • Motor capture
  • Multimedia, audio/video processing and animation
  • Natural language processing
  • Quantum computing
  • Robotic process automation
  • Search engines
  • Signal processing
  • Software applications and systems, mobile applications, user interfaces
Consumer Goods and Retail
  • Anti-counterfeit devices
  • Beauty
  • Fashion
  • Health, fitness and sport
  • Household goods
  • Luxury goods
  • Moda
  • Retail
Electronics and Electrical Devices
  • Computer and IT architecture and system design
  • Medical devices
  • Optics
  • Restaurants and bars
  • Robotics
  • Scientific instruments
  • Semiconductor devices
  • Testing systems, control systems, signal processing
  • Travel and leisure
  • Wearable tech and human interfaces
Energy and Green Technologies
  • Biofuels
  • Clean air
  • Fuel cells and battery technology
  • Renewables and recycling
  • Solar power
  • Water, oil and gas, nuclear, fusion, fission
  • Wind turbines
Food and Beverage
  • Beverages
  • Nutrition
  • Retail
Industrial Manufacturing and Processing
  • Packaging
  • Polymers and plastics
  • Printing tech
  • Additive manufacturing
  • Coatings
  • Construction
Materials
  • Advanced materials
  • Composite materials
  • Metallurgy and alloys
  • Nanotechnology
Medical Devices and Diagnostics
  • Artificial intelligence
  • Devices
  • Diagnostic instruments
  • Digital health
  • Drug delivery
  • Immuno-oncology
  • In vitro diagnostics
  • Medtech
Pharmaceuticals
  • Diagnostics
  • Drug delivery
  • Generic market entry
  • Medicinal chemistry
  • Methods of production and synthesis
  • Personalised medicine/disease biomarkers
  • Pharmaceutical formulations
  • Pharmaceuticalsceutical formulations
  • Polymorphs
  • Small molecule pharmaceuticals
  • Supplementary protection certificates (SPCs)
Trade Marks
  • Consumer goods
  • Cosmetics and perfumery
  • Financial services
  • Mechanical engineering
  • Mechanical products
  • Services
  • Telecommunications